Assessment of experimental malaria vaccine induced protection in pre-exposed populations

Affiliations

¹ Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: claudia.daubenberger@unibas.ch.

Comment

Claudia Daubenberger. Lancet Infect Dis. 2022 Mar.

. 2022 Mar;22(3):305-307.

doi: 10.1016/S1473-3099(21)00359-5. Epub 2021 Nov 18.

¹ Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: claudia.daubenberger@unibas.ch.

No abstract available

Conflict of interest statement

I declare no competing interests.

Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Sissoko MS, Healy SA, Katile A, Zaidi I, Hu Z, Kamate B, Samake Y, Sissoko K, Mwakingwe-Omari A, Lane J, Imeru A, Mohan R, Thera I, Guindo CO, Dolo A, Niare K, Koïta F, Niangaly A, Rausch KM, Zeguime A, Guindo MA, Bah A, Abebe Y, James ER, Manoj A, Murshedkar T, Kc N, Sim BKL, Billingsley PF, Richie TL, Hoffman SL, Doumbo O, Duffy PE. Sissoko MS, et al. Lancet Infect Dis. 2022 Mar;22(3):377-389. doi: 10.1016/S1473-3099(21)00332-7. Epub 2021 Nov 18. Lancet Infect Dis. 2022. PMID: 34801112 Free PMC article. Clinical Trial.